NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Newsletters
Advertisement
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
HONcode
Security by Verisign

AIDS Weekly


Susan Hasty, Publisher
Table of Contents . . . November 19th, 2001
Non-Subscriber - Summaries Only
Related Areas: Other Issues in AIDS Weekly | Other Publications

AIDS And HIV Therapy - DHEA Replacement Therapy Effective

HIV Dementia - P-glycoprotein May Prevent Microglia Exposure To Therapeutic Drugs

AIDS And HIV Therapy - Prednisone Ineffective Against Nevirapine-Induced Rash

AIDS And HIV Vaccine - Viral Protein Alterations Have Similar Impact On HIV, SHIV Specific Antibodies

Immunology - Herpesvirus 6 Prevents HIV Variant From Spreading In Humans

AIDS And HIV Tuberculosis - Coinfection Does Not Appear To Augment TB Infectivity

AIDS And HIV Vaccine - New Details About Epitope Targeted By Potent Monoclonal Antibody

 AIDS Therapies - Improved Dosing Formulations For Investigational Drug In Development

Diagnosis - FDA Approves Investigational Device Exemption For Efoora HIV Rapid Test

Drug Development - Article Describes New "Golden Age" Of Antiviral Drugs And Vaccines

HIV Research - Visible Genetics Genotyping Kit To Be Used In GlaxoSmithKline Trial

Hepatitis C Virus - Treatment Strategy Doubles Efficacy In HIV Coinfected Patients

Non-Hodgkin Lymphoma - Phase I Clinical Trial Of SL11047 Commence In AIDS Patients

Risk Factors - Success Of HIV Therapy May Discourage Safe Sex

Tuberculosis Therapy - Isoniazid Hepatotoxicity Not Increased In Hepatitis C Patients


Return to Top of Page

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login